Histogen, Inc. engages in the development of patented, innovative technologies that replace and regenerate tissues in the body for the aesthetic and therapeutic markets. Its technology is based on the discovery that growing fibroblast cells under simulated embryonic conditions induces them to become multipotent stem cells. The environment created by its proprietary process mimics the conditions within the womb very low oxygen and suspension. When cultured under these conditions, the induced multipotent stem cells generate biological materials that stimulate a patient's own stem cells to activate and regenerate tissue. This results in potential therapeutic benefits in multiple treatment settings, including skin care, orthopedic indications such as cartilage formation and spinal disc repair, wound healing and dermal fillers. The company was founded on July 13, 2005 by Steven J. Mento and is headquartered in San Diego, CA.
Company profile
Website
CEO
Richard W. Pascoe
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
260461023
Latest filings (excl ownership)
D/A
$30M in equity, sold $15.33M, 47 investors
17 Sep 19
D
$6M in equity, sold $6M, 1 investor
29 Aug 16
D/A
$9.49M in equity, sold $9.49M, 65 investors
29 Jun 15
D/A
$18M in equity
29 Jun 15
D/A
$5.25M in equity, sold $5.25M, 34 investors
29 Jun 15
D/A
$10.39M in equity, sold $10.39M, 2 investors
29 Jun 15
D
$10.39M in equity, 2 investors
24 Jun 15
D
$5.25M in equity, 34 investors
24 Jun 15
D
$9.49M in equity, 65 investors
24 Jun 15
D
$18M in equity
24 Jun 15
Latest ownership filings
No filings
Institutional ownership, Q3 2020
23.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 21 |
Opened positions | 3 |
Closed positions | 3 |
Increased positions | 3 |
Reduced positions | 4 |
13F shares | Current |
---|---|
Total value | 66.49 mm |
Total shares | 585.96 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 124.30 k | $204.00 k |
Renaissance Technologies | 105.76 k | $173.00 k |
Acadian Asset Management | 81.83 k | $134.00 k |
United Capital Financial Advisers | 80.75 k | $132.00 k |
BLK Blackrock | 64.50 k | $106.00 k |
IPG Investment Advisors | 40.00 k | $65.60 mm |
Geode Capital Management | 23.91 k | $39.00 k |
Raymond James & Associates | 17.17 k | $28.00 k |
BK Bank Of New York Mellon | 13.75 k | $23.00 k |
Parametric Portfolio Associates | 11.39 k | $19.00 k |